A new Labor Department regulation will soon require pharmacy-benefit managers to disclose details about how they are paid to employers. The rule mandates transparency in the compensation arrangements between drug middlemen and the companies that hire them to manage prescription drug benefits.
Pharmacy-benefit managers, or PBMs, act as intermediaries between drug manufacturers, insurers, and pharmacies. They negotiate drug prices and rebates on behalf of employers and health plans. Critics have long argued that PBMs operate with too little transparency, making it difficult for employers to understand exactly how much these middlemen earn from the drug supply chain.
The new regulation aims to shed light on PBM payment structures by requiring them to share compensation details with employers. This disclosure requirement is part of broader federal efforts to increase transparency in healthcare pricing and reduce prescription drug costs. Employers will gain clearer insight into the fees and rebates that flow through PBMs, potentially allowing them to negotiate better terms and lower overall drug spending.
Source: Wall Street Journal US Business · Summarized by HeadlinesBriefing